Nils Steinacker
Has participated in:
-
Reserpine-induced rat model for depression: Behavioral, physiological and PET-based dopamine receptor availability validation
-
A new class of PSMA-617-based hybrid molecules for preoperative imaging and intraoperative fluorescence navigation of prostate cancer
-
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside